Norden Group LLC lowered its holdings in Haleon plc (NYSE:HLN - Free Report) by 51.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,578 shares of the company's stock after selling 25,226 shares during the period. Norden Group LLC's holdings in Haleon were worth $225,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Addison Advisors LLC raised its stake in shares of Haleon by 28.7% in the fourth quarter. Addison Advisors LLC now owns 4,954 shares of the company's stock valued at $47,000 after buying an additional 1,106 shares during the period. Synovus Financial Corp raised its stake in shares of Haleon by 0.8% in the third quarter. Synovus Financial Corp now owns 148,834 shares of the company's stock valued at $1,575,000 after buying an additional 1,216 shares during the period. Greenleaf Trust raised its stake in shares of Haleon by 8.4% in the fourth quarter. Greenleaf Trust now owns 17,225 shares of the company's stock valued at $164,000 after buying an additional 1,333 shares during the period. Baron Wealth Management LLC raised its stake in shares of Haleon by 4.3% in the fourth quarter. Baron Wealth Management LLC now owns 33,632 shares of the company's stock valued at $321,000 after buying an additional 1,381 shares during the period. Finally, Peapack Gladstone Financial Corp raised its stake in shares of Haleon by 3.2% in the third quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company's stock valued at $474,000 after buying an additional 1,390 shares during the period. Hedge funds and other institutional investors own 6.67% of the company's stock.
Analyst Ratings Changes
HLN has been the topic of several research reports. HSBC restated a "hold" rating on shares of Haleon in a research note on Wednesday. Sanford C. Bernstein lowered Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research note on Friday, January 10th. Finally, Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Five investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $10.95.
Read Our Latest Research Report on HLN
Haleon Stock Performance
Shares of NYSE:HLN traded up $0.06 during midday trading on Friday, reaching $10.45. 10,381,006 shares of the company traded hands, compared to its average volume of 6,535,003. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The firm has a market capitalization of $47.29 billion, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. The firm's fifty day moving average price is $9.66 and its two-hundred day moving average price is $9.86.
Haleon (NYSE:HLN - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, equities analysts expect that Haleon plc will post 0.43 earnings per share for the current year.
Haleon Increases Dividend
The firm also recently announced a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a $0.1166 dividend. This is a positive change from Haleon's previous -- dividend of $0.05. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio is currently 58.97%.
About Haleon
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Articles
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
